Geode Capital Management’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.23M | Sell |
495,343
-470,256
| -49% | -$1.17M | ﹤0.01% | 3269 |
|
|
2025
Q1 | $1.5M | Buy |
965,599
+6,283
| +0.7% | +$9.74K | ﹤0.01% | 3156 |
|
|
2024
Q4 | $2.05M | Buy |
959,316
+14,439
| +2% | +$30.9K | ﹤0.01% | 3112 |
|
|
2024
Q3 | $4.11M | Buy |
944,877
+102,445
| +12% | +$446K | ﹤0.01% | 2864 |
|
|
2024
Q2 | $3.93M | Buy |
842,432
+459,819
| +120% | +$2.14M | ﹤0.01% | 2857 |
|
|
2024
Q1 | $1.94M | Buy |
382,613
+32,167
| +9% | +$163K | ﹤0.01% | 3123 |
|
|
2023
Q4 | $985K | Buy |
350,446
+26,155
| +8% | +$73.5K | ﹤0.01% | 3363 |
|
|
2023
Q3 | $931K | Buy |
324,291
+53,084
| +20% | +$152K | ﹤0.01% | 3352 |
|
|
2023
Q2 | $1.37M | Buy |
271,207
+779
| +0.3% | +$3.93K | ﹤0.01% | 3235 |
|
|
2023
Q1 | $511K | Buy |
270,428
+5,138
| +2% | +$9.71K | ﹤0.01% | 3637 |
|
|
2022
Q4 | $477K | Buy |
265,290
+743
| +0.3% | +$1.34K | ﹤0.01% | 3679 |
|
|
2022
Q3 | $447K | Buy |
264,547
+17,839
| +7% | +$30.1K | ﹤0.01% | 3778 |
|
|
2022
Q2 | $606K | Sell |
246,708
-185,316
| -43% | -$455K | ﹤0.01% | 3653 |
|
|
2022
Q1 | $1.2M | Buy |
432,024
+35,857
| +9% | +$99.3K | ﹤0.01% | 3530 |
|
|
2021
Q4 | $2.11M | Buy |
396,167
+46,187
| +13% | +$246K | ﹤0.01% | 3338 |
|
|
2021
Q3 | $2.96M | Sell |
349,980
-9,622
| -3% | -$81.4K | ﹤0.01% | 3187 |
|
|
2021
Q2 | $4.38M | Buy |
359,602
+62,165
| +21% | +$758K | ﹤0.01% | 2984 |
|
|
2021
Q1 | $7.22M | Buy |
297,437
+27,512
| +10% | +$667K | ﹤0.01% | 2585 |
|
|
2020
Q4 | $8.65M | Buy |
269,925
+22,199
| +9% | +$711K | ﹤0.01% | 2273 |
|
|
2020
Q3 | $7.49M | Buy |
247,726
+65,962
| +36% | +$1.99M | ﹤0.01% | 2144 |
|
|
2020
Q2 | $7.66M | Buy |
181,764
+91,367
| +101% | +$3.85M | ﹤0.01% | 2090 |
|
|
2020
Q1 | $2.26M | Buy |
+90,397
| New | +$2.26M | ﹤0.01% | 2609 |
|